To determine any relationship between oncogenic activation and loss of tumor suppressor function in the GPCR-mediated PI3K pathway, mutations in the LPAR4, PIK3CA, and PTEN mutations were analyzed in relation to each other both in pan-cancer cell lines and pan-solid tumor samples (Table 4). This evidence concerns the gene LPAR4 and cancer.